Credit Suisse analyst A.J. Rice initiated coverage of Amedisys with an Outperform rating and $206 price target. Amedisys is the third largest provider of home health services and hospice services in the United States. Home health and hospice represent one of the fastest-growing segments of healthcare services, riding the demographic wave of aging baby boomers, Rice tells investors in a research note. Over the next two years, excluding any uncompleted acquisitions, the analyst expects double-digit adjusted EBITDA and adjusted earnings growth from the company.